Physician profile
James S Magera
NPI 1316927544
$4,088.47
in general payments reported to CMS, 2019-2025
38 companies · $949 in 2025
The $949 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $786 · 2020: $183 · 2021: $482 · 2022: $734 · 2023: $508 · 2024: $446 · 2025: $949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,612 · Education: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,611.52 |
| Education | $292.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,094.47 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $627.89 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Abbvie INC. | $310.81 | 2019-2025 | |
| Histosonics, INC. | $297.44 | 2025 | |
| Antares Pharma, INC. | $262.40 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Olympus America INC. | $158.50 | 2019-2025 | Itind System |
| 180 Medical, INC. | $105.64 | 2021-2023 | Gentlecath |
| Zyla Life Sciences, INC. | $96.21 | 2019-2020 | |
| Tolmar, INC. | $90.71 | 2023-2025 | Eligard, Jatenzo |
| Boston Scientific Corporation | $77.51 | 2019-2021 | |
| Pfizer INC. | $75.42 | 2019 | |
| Laborie Medical Technologies Corp. | $71.69 | 2023-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Blue Earth Diagnostics | $70.55 | 2019-2024 | |
| Janssen Biotech, INC. | $68.66 | 2019-2020 | |
| Travere Therapeutics, INC. | $63.32 | 2019-2025 | Thiola |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $57.51 | 2022-2023 | Porges Coloplast |
| Progenics Pharmaceuticals, INC. | $49.96 | 2023-2024 | Pylarify |
| Urovant Sciences INC | $35.30 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Amgen INC. | $33.03 | 2019-2020 | |
| Convatec INC. | $32.66 | 2021-2025 | |
| Halozyme INC | $32.54 | 2023 | |
| Immunitybio, INC. | $29.80 | 2025 | |
| Endo Pharmaceuticals INC. | $28.33 | 2022 | |
| Allergan, INC. | $26.89 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.12 | 2022 | |
| Ferring Pharmaceuticals INC. | $23.72 | 2019 | |
| Medtronic USA, INC. | $21.41 | 2020 | |
| Urogen Pharma, INC. | $20.93 | 2025 | |
| Hollister Incorporated | $20.56 | 2022 | |
| Alnylam Pharmaceuticals INC. | $20.42 | 2022 | |
| Dendreon Pharmaceuticals LLC | $20.30 | 2020 | |
| Clarus Therapeutics INC. | $19.90 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.42 | 2025 | |
| Karl Storz Endoscopy-America | $18.20 | 2021 | |
| Myriad Genetic Laboratories, INC. | $17.27 | 2021 | |
| Teleflex LLC | $15.72 | 2025 | Urolift |
| Intuitive Surgical, INC. | $13.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Magera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.